Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4236693 | 0.78 | — | — | |
| SCHEMBL4070843 | 0.78 | CCR1 (0.39) | HTTEPHX1 | |
| SCHEMBL7583317 | 0.76 | CYP2C19 (0.37) | CYP2C19CYP2C9HTTEPHX1CYP1A2 | |
| SCHEMBL7581837 | 0.74 | SMN1; SMN2 (0.37) | CYP2C19 | |
| SCHEMBL4065712 | 0.74 | SMN1; SMN2 (0.37) | CYP2C19 | |
| SCHEMBL4063930 | 0.74 | CCR1 (0.34) | — | |
| SCHEMBL4069430 | 0.73 | EPHX1 (0.38) | EPHX1 | |
| SCHEMBL4058962 | 0.73 | EPHX1 (0.39) | EPHX1 | |
| SCHEMBL4060331 | 0.72 | CCR1 (0.35) | CYP2C19 | |
| SCHEMBL4067877 | 0.72 | CCR1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020198207-A1 | Novel Hexanoic acid derivatives | KATH JOHN CHARLES (US) | 2002-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020198207-A1 | Novel Hexanoic acid derivatives | HCAR3, HCAR1, FFAR1 | CYP2C19 3140/4885CYP2C9 1975/4885HTT 3357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.